{
  "paper_metadata": {
    "pmid": "23704879",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for BRCA2, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": null,
      "protein_notation": "p.Ser196Ile",
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": null,
        "demographics": null,
        "phenotype": null
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Altered the consensus kinase motif for Ser193.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "predicted to affect phosphorylation",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is one of three BRCA2 VUS highlighted as potentially clinically significant.",
      "key_quotes": [
        "three BRCA2 (S196I, T207A, P3292L) VUS as potentially clinically significant."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": null,
      "protein_notation": "p.Thr207Ala",
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": null,
        "demographics": null,
        "phenotype": null
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Directly altered the phosphorylated Threonine residue and completely abolished kinase binding at Thr207.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "predicted to affect phosphorylation",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is one of three BRCA2 VUS highlighted as potentially clinically significant.",
      "key_quotes": [
        "three BRCA2 (S196I, T207A, P3292L) VUS as potentially clinically significant."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": null,
      "protein_notation": "p.Pro3292Leu",
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": null,
        "demographics": null,
        "phenotype": null
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Altered the sequence for CDK2 binding for Ser3291.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "predicted to affect phosphorylation",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This variant is one of three BRCA2 VUS highlighted as potentially clinically significant.",
      "key_quotes": [
        "three BRCA2 (S196I, T207A, P3292L) VUS as potentially clinically significant."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 3,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted from the text."
  }
}